Czechia – Antineoplastic agents – Dodávky léků – Léčivá látka lorlatinib – ATC L01ED05

The subject of the Public Contract is the ongoing supply of medicinal product containing the active substance lorlatinib – ATC L01ED05. LL - lorlatinib, dosage form 100MG TBL FLM 30, unit of measure 30X100MG, quantity 600 LL - lorlatinib, dosage form 25MG TBL FLM 90, unit of measure 90X25MG, quantity 300